Biogen Inc Stock Buy Hold or Sell Recommendation

BIIB Stock  USD 226.40  1.15  0.51%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Biogen Inc is 'Buy'. Macroaxis provides Biogen buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Biogen positions.
  
Check out Biogen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Biogen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Execute Biogen Buy or Sell Advice

The Biogen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biogen Inc. Macroaxis does not own or have any residual interests in Biogen Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biogen's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell BiogenBuy Biogen
Buy

Market Performance

GoodDetails

Volatility

Very steadyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Not AvailableDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Biogen Inc has a Risk Adjusted Performance of 0.1025, Jensen Alpha of 0.19, Total Risk Alpha of 0.0105, Sortino Ratio of 0.092 and Treynor Ratio of 0.3534
Macroaxis provides advice on Biogen Inc to complement and cross-verify current analyst consensus on Biogen Inc. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Biogen is not overpriced, please confirm all Biogen Inc fundamentals, including its shares owned by institutions, price to sales, net income, as well as the relationship between the price to earning and gross profit . Given that Biogen Inc has a price to earning of 14.83 X, we suggest you to validate Biogen Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Biogen Trading Alerts and Improvement Suggestions

Biogen Inc has a poor financial position based on the latest SEC disclosures
Over 93.0% of the company shares are held by institutions such as insurance companies

Biogen Returns Distribution Density

The distribution of Biogen's historical returns is an attempt to chart the uncertainty of Biogen's future price movements. The chart of the probability distribution of Biogen daily returns describes the distribution of returns around its average expected value. We use Biogen Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biogen returns is essential to provide solid investment advice for Biogen.
Mean Return
0.26
Value At Risk
-2.83
Potential Upside
3.16
Standard Deviation
1.76
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biogen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Biogen Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biogen or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biogen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biogen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.19
β
Beta against Dow Jones0.72
σ
Overall volatility
1.76
Ir
Information ratio 0.09

Biogen Volatility Alert

Biogen Inc has relatively low volatility with skewness of -0.07 and kurtosis of -0.27. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biogen's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biogen's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Biogen Fundamentals Vs Peers

Comparing Biogen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biogen's direct or indirect competition across all of the common fundamentals between Biogen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biogen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biogen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Biogen to competition
FundamentalsBiogenPeer Average
Return On Equity0.0805-0.31
Return On Asset0.0486-0.14
Profit Margin0.12 %(1.27) %
Operating Margin0.27 %(5.51) %
Current Valuation38.67 B16.62 B
Shares Outstanding145.6 M571.82 M
Shares Owned By Insiders0.15 %10.09 %
Shares Owned By Institutions93.00 %39.21 %
Number Of Shares Shorted2.74 M4.71 M
Price To Earning14.83 X28.72 X
Price To Book1.95 X9.51 X
Price To Sales2.93 X11.42 X
Revenue9.84 B9.43 B
Gross Profit7.9 B27.38 B
EBITDA2.6 B3.9 B
Net Income1.16 B570.98 M
Cash And Equivalents4.91 B2.7 B
Cash Per Share34.10 X5.01 X
Total Debt7.34 B5.32 B
Debt To Equity0.52 %48.70 %
Current Ratio2.49 X2.16 X
Book Value Per Share104.48 X1.93 K
Cash Flow From Operations1.55 B971.22 M
Short Ratio2.48 X4.00 X
Earnings Per Share8.00 X3.12 X
Price To Earnings To Growth6.24 X4.89 X
Target Price279.54
Number Of Employees7.57 K18.84 K
Beta-0.038-0.15
Market Capitalization32.8 B19.03 B
Total Asset26.84 B29.47 B
Retained Earnings17.63 B9.33 B
Working Capital3.42 B1.48 B
Note: Disposition of tradable shares by Singhal Priya of Biogen at 213.09 subject to Rule 16b-3 [view details]

Biogen Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biogen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Biogen Buy or Sell Advice

When is the right time to buy or sell Biogen Inc? Buying financial instruments such as Biogen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Biogen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Strategy ETFs Thematic Idea Now

Strategy ETFs
Strategy ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1218 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Biogen Stock

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Biogen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.